Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

Psilocybin, the active compound in "magic mushrooms," has seen a surge in medical research over the past few years, ...

For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can ...

Melatonin will become available over the counter, and psilocybin - magic mushrooms - will be available for patients with treatment-resistant depression, David Seymour has announced.

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.

Associate Health Minister David Seymour says the Government is delivering on its promise to cut red tape and give Kiwis ...

Associate Health Minister David Seymour says the Government is delivering on its promise to cut red tape and give Kiwis greater access to more ...